Pharma Deals Review, Vol 2008, No 96 (2008)

Font Size:  Small  Medium  Large

BMS Bags a Bargain

Sally Mardikian PhD

Abstract


BMS has agreed to buy Kosan Biosciences for US$190 M. For a company with a Phase III product in its pipeline, did Kosan get what it deserves?

Full Text: pdf html

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.